Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
936.35
-6.20 (-0.66%) Zydus Lifesciences informs about press release
Date: 06-05-2022Zydus Lifesciences has informed that it enclosed Press release dated May 6, 2022 titled 'Zydus receives tentative approval from USFDA for Selexipag Tablets'.
The above information is a part of company’s filings submitted to BSE.